Your browser doesn't support javascript.
loading
Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea.
Demirev, Atanas V; Lee, Kyuyoung; Bae, Joon-Yong; Park, Heedo; Park, Sejik; Kim, Hyunbeen; Lee, Jungmin; Cho, Junhyung; Yang, Jeong-Sun; Kim, Kyung-Chang; Lee, Joo-Yeon; Kim, Kisoon; Lemey, Philippe; Park, Man-Seong; Kim, Jin Il.
  • Demirev AV; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
  • Lee K; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
  • Bae JY; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
  • Park H; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
  • Park S; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
  • Kim H; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
  • Lee J; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
  • Cho J; Division of Emerging Viral Diseases and Vector Research, Center for Infectious Diseases Research, National Institute of Infectious Diseases, Korea National Institute of Health, Osong, Republic of Korea.
  • Yang JS; Division of Emerging Viral Diseases and Vector Research, Center for Infectious Diseases Research, National Institute of Infectious Diseases, Korea National Institute of Health, Osong, Republic of Korea.
  • Kim KC; Division of Emerging Viral Diseases and Vector Research, Center for Infectious Diseases Research, National Institute of Infectious Diseases, Korea National Institute of Health, Osong, Republic of Korea.
  • Lee JY; Center for Infectious Diseases Research, National Institute of Infectious Diseases, Korea National Institute of Health, Osong, Republic of Korea.
  • Kim K; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
  • Lemey P; Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea.
  • Park MS; Department of Microbiology, Immunology, and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
  • Kim JI; Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
iScience ; 26(9): 107689, 2023 Sep 15.
Article en En | MEDLINE | ID: mdl-37680469
ABSTRACT
SARS-CoV-2 variants have continuously emerged globally, including in South Korea. To characterize the molecular evolution of SARS-CoV-2 in South Korea, we performed phylogenetic and genomic recombination analyses using more than 12,000 complete genome sequences collected until October 2022. The variants in South Korea originated from globally identified variants of concern and harbored genetic clade-common and clade-specific amino acid mutations mainly around the N-terminal domain (NTD) or receptor binding domain (RBD) in the spike protein. Several point mutation residues in key antigenic sites were under positive selection persistently with changing genetic clades of SARS-CoV-2. Furthermore, we detected 17 potential genomic recombinants and 76.4% (13/17) retained the mosaic NTD or RBD genome. Our results suggest that point mutations and genomic recombination in the spike contributed to the molecular evolution of SARS-CoV-2 in South Korea, which will form an integral part of global prevention and control measures against SARS-CoV-2.
Palabras clave